ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,010.60
0.00%
US Tech 100
16,784.80
0.19%
Dow Jones
38,239.98
0.00%
Brent Oil
85.485
-1.07%
Bitcoin
66,031.34
-1.24%
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE

  6. Bio Rad Laboratories Inc (BIO.B) Quote

Bio Rad Laboratories Inc

Bio Rad Laboratories Inc (BIO.B)

NYSE
279.91
0.00
(0.00%)
Closed April 22 4:00PM
Delayed by 15 minutes
279.91
0.00
( 0.00% )
Pre Market: 7:30AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
279.91
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
271.00 52 Week Range 470.09
Market Cap
7.983B
Previous Close
279.91
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
326
Shares Outstanding
28,518,436
Dividend Yield
-
PE Ratio
-12.53
Earnings Per Share (EPS)
-22.35
Revenue
2.67B
Net Profit
-637.32M

About Bio Rad Laboratories Inc

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for c... Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier. Show more

Sector
Lab Analytical Instruments
Industry
Lab Analytical Instruments
Website
www.bio-rad.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Bio Rad Laboratories Inc is listed in the Lab Analytical Instruments sector of the New York Stock Exchange with ticker BIO.B. The last closing price for Bio Rad Laboratories was $279.91. Over the last year, Bio Rad Laboratories shares have traded in a share price range of $ 271.00 to $ 470.09.

Bio Rad Laboratories currently has 28,518,436 shares outstanding. The market capitalization of Bio Rad Laboratories is $7.98 billion. Bio Rad Laboratories has a price to earnings ratio (PE ratio) of -12.53.

BIO.B Latest News

More News

Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the first quarter of 2024 on...

April 18 2024
Business Wire

Bio-Rad’s Chief Operating Officer Andrew Last to Retire

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Dr. Andrew Last, Executive Vice President and...

April 10 2024
Business Wire

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

March 11 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

February 29 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

February 28 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

February 28 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

February 27 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

February 27 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-28.39-9.2085630879308.3338.55275.65119285.82327731CS
4-52.29-15.7405177604332.2350.09275.65107319.02098901CS
12-53.09-15.9429429429333357.67275.65326333.90189876CS
26-37.35-11.7726785602317.26357.67271215327.15531245CS
52-190.18-40.4560828777470.09470.09271132338.65514702CS
156-353.82-55.8313477348633.73879271113505.64930589CS
260-31.65-10.1585569393311.56879271155461.76390524CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CYNCYNGN Inc
$ 0.2305
(90.50%)
64.22M
PEGYPineapple Energy Inc
$ 0.0658
(43.67%)
65.86M
HWHHWH International Inc
$ 1.75
(36.72%)
9.73M
NKGNNKGen Biotech Inc
$ 1.92
(30.61%)
3.16M
SMFLSmart for Life Inc
$ 5.64
(29.66%)
964.6k
ABEOAbeona Therapeutics Inc
$ 3.92
(-46.74%)
150.62k
GWAVGreenwave Technology Solutions Inc
$ 0.0689
(-45.45%)
5.09M
AUIDauthID Inc
$ 6.18
(-19.64%)
3.21k
HUGEFSD Pharma Inc
$ 0.4001
(-18.18%)
1
OCXOncocyte Corporation
$ 2.10
(-16.33%)
310
PEGYPineapple Energy Inc
$ 0.0658
(43.67%)
65.86M
CYNCYNGN Inc
$ 0.2305
(90.50%)
64.22M
HWHHWH International Inc
$ 1.75
(36.72%)
9.73M
AGBAAGBA Group Holding Ltd
$ 2.88
(15.20%)
5.67M
JAGXJaguar Health Inc
$ 0.1643
(-8.67%)
5.52M

Discussion

View Full Feed
al44 al44 1 minute ago
Just sayin-

https://i0.wp.com/politicallyincorrecthumor.com/wp-content/uploads/2024/04/things-dont-feel-guilty-trolling-liberals-guns-happiness.jpg?w=533&ssl=1
Doubledown75 Doubledown75 2 minutes ago
When he starts posting that’s the sign:)
SPY
al44 al44 2 minutes ago
Famous democrat initials-

https://i0.wp.com/politicallyincorrecthumor.com/wp-content/uploads/2024/04/lbj-jfk-fdr-fjb.jpg?w=520&ssl=1
Clootch Clootch 2 minutes ago
$RONN https://x.com/stockinfocus_/status/1782742746530472140
RONN
georgie18 georgie18 2 minutes ago
MOB...$1.17...NEWS...Shoham, Israel, April 23, 2024 (GLOBE NEWSWIRE) -- Mobilicom Limited (Nasdaq: MOB, MOBBW), a provider of cybersecurity and robust solutions for drones and robotics, today announced the launch of its most cutting-edge product to date, the OS3 Platform, a comprehensive software so
gp22 gp22 3 minutes ago
$PDYN @ $1.40s; AI Software for robotics
One of hottest sectors of AI. Retrofit too
Low float cash 6 CXAI type AI meme play....
I called cxai in $1.20
DONT MISS $PDYN
CXAI PDYN
prototype_101 prototype_101 3 minutes ago
Investors have learned INCREDIBLE Developments in 2024 so far!!! here is a summary of things investors have learned form OFC in March 2024, and Lebby's LD Micro Interview in April, as well as Lebby's Belgium visit/presentations in April

1) Lebby has LWLG modulators being implemented a
ASM LWLG
DarkB4Dawn DarkB4Dawn 3 minutes ago
Future Value (FV) of the Continuously Compounded @ 5% ~$652,174,860.47
Total Interest $274,174,860.47
Total Contributions - 18M per qtr. x 20 qtrs.
$360,000,000.00

minus what the trustee(s) is being compensated. My Napkin...
COOP
Iwasbornpoor Iwasbornpoor 3 minutes ago
Try looking up the company again. It is not actively a company right now
PLPL
georgie18 georgie18 3 minutes ago
MOB...$1.17...NEWS...Shoham, Israel, April 23, 2024 (GLOBE NEWSWIRE) -- Mobilicom Limited (Nasdaq: MOB, MOBBW), a provider of cybersecurity and robust solutions for drones and robotics, today announced the launch of its most cutting-edge product to date, the OS3 Platform, a comprehensive software
resx18 resx18 3 minutes ago
Good Morning $CBDW
CBDW
sharkey1 sharkey1 3 minutes ago
No end in sight
https://abc7.com/adhd-drug-shortage-adderall-ritalin-coping-tips/14697865/
Can't get that new plant built fast enough.
ELTP
jedijazz jedijazz 4 minutes ago
$AGBA - Rockstar CEOs Make Triller a New Giant
https://pbs.twimg.com/media/GL2UfpuWkAExzMs?format=jpg&name=medium
AGBA
Clootch Clootch 4 minutes ago
$PDGO https://x.com/DACE0325/status/1782743409276403863
PDGO
oystersnbeer oystersnbeer 4 minutes ago
Tell it to a Cristofascist .

https://encrypted-tbn3.gstatic.com/images?q=tbn:ANd9GcTgFk7yHVp0dyu5ny9XyOxZf8aArfDZIta-RXz6I5inZ3Y5PjG0
DJT
stockprofitter stockprofitter 4 minutes ago
Look it up and see for yourself! If I’m wrong so be it, but I’m not.

Everyone here is entitled to opinion as are you :)
FNMA
sirant sirant 4 minutes ago
GOOD MORNING EVERYONE

GO $MCIC
MCIC
trademax42 trademax42 4 minutes ago
Good morning everyone!! Getting close by the day!
IGPK
Moon Bot Moon Bot 5 minutes ago
I'm going to sell my shares for a profit, period.

Enjoy your day guys, that's including the three stooges
MONI
harry crumb harry crumb 5 minutes ago
It very well might
AGBA
karmakaziXpert karmakaziXpert 6 minutes ago
Kazi appreciates the compliment.

She hasn't forgot about how wrong those, like yourself, have been about the company and its fearless leader, for many years.

Kazi knows what Kazi knows. Some should have paid much more attention to the egotistical maniac. She's been o
SNPW
linkvest linkvest 6 minutes ago
Barchart Technical Opinion

STRONG BUY

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.
IGPK
Emannow Emannow 6 minutes ago
Yes, there is no head to head comparison published! One must compare the data from both PI’s.

Allergan will never tell patients that their active toxin floats around for up to 2 weeks in the patient’s tissues! Easy to understand why Daxi with the same active ingredient as Botox giv
RVNC
shurtha2000 shurtha2000 6 minutes ago
SBFM $1.26 How low are they going to drop this
SBFM

Your Recent History

NYSE
BIO.B
Bio Rad Laboratories
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved